0.5753
Schlusskurs vom Vortag:
$0.575
Offen:
$0.59
24-Stunden-Volumen:
532.48K
Relative Volume:
0.60
Marktkapitalisierung:
$49.57M
Einnahmen:
$2.24M
Nettoeinkommen (Verlust:
$-136.67M
KGV:
-0.2512
EPS:
-2.29
Netto-Cashflow:
$-102.08M
1W Leistung:
-0.54%
1M Leistung:
-1.13%
6M Leistung:
-35.43%
1J Leistung:
-76.33%
Century Therapeutics Inc Stock (IPSC) Company Profile
Firmenname
Century Therapeutics Inc
Sektor
Branche
Telefon
215-981-4000
Adresse
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Vergleichen Sie IPSC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
IPSC
Century Therapeutics Inc
|
0.5753 | 49.83M | 2.24M | -136.67M | -102.08M | -2.29 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-08-08 | Eingeleitet | Rodman & Renshaw | Buy |
2023-08-28 | Herabstufung | JP Morgan | Overweight → Neutral |
2022-12-27 | Eingeleitet | Chardan Capital Markets | Buy |
2022-10-31 | Eingeleitet | Guggenheim | Buy |
2022-10-10 | Eingeleitet | Canaccord Genuity | Buy |
2022-05-23 | Eingeleitet | H.C. Wainwright | Buy |
2022-05-12 | Eingeleitet | William Blair | Mkt Perform |
2021-07-13 | Eingeleitet | BofA Securities | Buy |
2021-07-13 | Eingeleitet | JP Morgan | Overweight |
2021-07-13 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Century Therapeutics Inc Aktie (IPSC) Neueste Nachrichten
What analysts say about Century Therapeutics Inc. stockHigh-impact investment strategies - jammulinksnews.com
Century Therapeutics Inc. Stock Analysis and ForecastFree Stock Market Return Analysis - Autocar Professional
All You Need to Know About Century Therapeutics (IPSC) Rating Upgrade to Strong Buy - Yahoo Finance
Is Century Therapeutics Inc. a good long term investmentMarket-leading capital gains - jammulinksnews.com
What drives Century Therapeutics Inc. stock priceConsistent double returns - jammulinksnews.com
Layoff Tracker: Following Challenges With DMD Therapy, Sarepta Will Cut 500 Employees - BioSpace
What institutions are buying Century Therapeutics Inc. stock nowFree Step-by-Step Investment Guide - Newser
University City biotech Century Therapeutics is cutting 72 jobs, about half its workforce - MSN
Why Century Therapeutics Inc. stock attracts strong analyst attentionMarket Trend Watch - Newser
Finance Watch: Karyopharm Cuts Jobs In Cash Crunch; Pacira’s Layoffs Attributed To Efficiency - insights.citeline.com
Century Therapeutics to Present Preclinical Data at EULAR 2025 Congress - MSN
How Century Therapeutics Inc. stock performs during market volatilityFree Stock Market Query - Newser
What makes Century Therapeutics Inc. stock price move sharplyRisk Limited High Gain Trades - Newser
Despite Fast-paced Momentum, Century Therapeutics (IPSC) Is Still a Bargain Stock - Yahoo Finance
Why OBIO stock attracts strong analyst attentionHigh Yield Stock Selection - Newser
Company’s Banking Stock: Dissecting a 51.83% Quarterly Revenue Decline Amid Growth - investchronicle.com
Century Therapeutics (NASDAQ:IPSC) Shares Down 0.9% – What’s Next? - Defense World
CFO changes at Biocryst, Xenon, Century, Pyxis - biocentury.com
Century Therapeutics to reduce headcount by 51% - MarketScreener
Century Therapeutics Announces Major Workforce Reduction - TipRanks
Century Therapeutics (IPSC) Is Attractively Priced Despite Fast-paced Momentum - Nasdaq
Head-To-Head Contrast: Quince Therapeutics (NASDAQ:QNCX) and Century Therapeutics (NASDAQ:IPSC) - Defense World
Century Therapeutics Holds Annual Stockholder Meeting By Investing.com - Investing.com South Africa
Century Therapeutics Holds Annual Stockholder Meeting - Investing.com Australia
Century Therapeutics Holds 2025 Annual Stockholders Meeting - TipRanks
66,797 Shares in Century Therapeutics, Inc. (NASDAQ:IPSC) Acquired by Two Sigma Investments LP - Defense World
Jane Street Group LLC Increases Stock Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World
Century Therapeutics, Inc. (NASDAQ:IPSC) Shares Acquired by Squarepoint Ops LLC - Defense World
Two Sigma Advisers LP Takes $52,000 Position in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World
Nuveen Asset Management LLC Raises Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain - sharewise
Deutsche Bank AG Purchases 173,849 Shares of Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World
Millennium Management LLC Grows Stock Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World
Finanzdaten der Century Therapeutics Inc-Aktie (IPSC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):